Safety and efficacy of sotorasib plus panitumumab and FOLFIRI for previously treated KRAS G12C-mutated metastatic colorectal cancer in the CodeBreaK 101 phase Ib study
- DOI
- 10.1016/j.esmoop.2026.108338
- Published
- 2026-09
- Container
- ESMO Open
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2026.108338,
title = {Safety and efficacy of sotorasib plus panitumumab and FOLFIRI for previously treated KRAS G12C-mutated metastatic colorectal cancer in the CodeBreaK 101 phase Ib study},
author = {T. Masuishi and J.H. Strickler and Y. Kuboki and M. Fakih and R. Greil and R. Galot and T.J. Price and E. Élez and S. Siena and J. Nolte-Hippenmeyer and C. Nduka and N. Strydom and C. Xia and D.S. Hong},
year = {2026},
journal = {ESMO Open},
doi = {10.1016/j.esmoop.2026.108338},
url = {https://doi.org/10.1016/j.esmoop.2026.108338}
}RIS
TY - JOUR TI - Safety and efficacy of sotorasib plus panitumumab and FOLFIRI for previously treated KRAS G12C-mutated metastatic colorectal cancer in the CodeBreaK 101 phase Ib study AU - T. Masuishi AU - J.H. Strickler AU - Y. Kuboki AU - M. Fakih AU - R. Greil AU - R. Galot AU - T.J. Price AU - E. Élez AU - S. Siena AU - J. Nolte-Hippenmeyer AU - C. Nduka AU - N. Strydom AU - C. Xia AU - D.S. Hong PY - 2026 JO - ESMO Open DO - 10.1016/j.esmoop.2026.108338 UR - https://doi.org/10.1016/j.esmoop.2026.108338 ER -
APA
Masuishi, T., Strickler, J., Kuboki, Y., Fakih, M., Greil, R., Galot, R., Price, T., Élez, E., Siena, S., Nolte-Hippenmeyer, J., Nduka, C., Strydom, N., Xia, C., & Hong, D. (2026). Safety and efficacy of sotorasib plus panitumumab and FOLFIRI for previously treated KRAS G12C-mutated metastatic colorectal cancer in the CodeBreaK 101 phase Ib study. ESMO Open. https://doi.org/10.1016/j.esmoop.2026.108338
Source records
- crossref · retrieved 2026-09-26T08:17:35.719Z